Sefer Gezer

Sefer Gezer, MD, is a Professor at Rush Medical College, Rush University, within the Department of Internal Medicine, Division of Hematology, Oncology, and Cell Therapy. He serves as the Director of Coagulation and Thrombosis at Rush, highlighting his leadership in this specialized clinical area. His primary clinical expertise lies in deep vein thrombosis, and he practices at the RUSH MD Anderson Cancer Center and its Oak Park location.

Dr. Gezer's research interests are deeply rooted in hematology, with a focus on thrombosis and coagulation disorders, antiphospholipid syndrome, myelodysplastic syndromes, and the hematologic implications of infectious diseases like COVID-19. His work bridges clinical practice and research, aiming to improve patient outcomes through a better understanding of blood disorders.

His publication record, spanning over two decades, shows a significant contribution to the understanding of thrombotic events in critical illness, particularly during the pandemic. His research trends indicate a consistent focus on clinical hematology, from studying genetic risk factors for bleeding before surgery to exploring novel combination therapies for myelodysplastic syndromes and the impact of blood type on COVID-19 severity.

Dr. Gezer received his medical degree from Hacettepe University Faculty of Medicine in Turkey and completed his residency in Hematology at Wayne State University.

He is an active member of the faculty, with no indication of retirement or a former staff status. His patient reviews consistently praise his thoroughness, clarity, and compassionate approach to care.

His laboratory and team focus is centered on coagulation and thrombosis, operating within the Hematology division at Rush Medical College. He collaborates extensively with other clinicians and researchers, as evidenced by his co-authorship on major clinical studies like the ACTIV-4C trial.